Clinical trial Recruiting at 2 sites Interventional Ages 50 to 85

Exercise intervention for lung regeneration in COPD patients

Official title: Activation of Regenerative Pathways by Exercise Training in Patients With Chronic Obstructive Pulmonary Disease

Run by Uppsala University · NCT06335992 · Data updated 2026-11-12

This study is testing if a special exercise program can help improve lung function and overall health in people with COPD by promoting lung healing.

Quick facts

Study typeInterventional
Ages50 Years to 85 Years
SexAll
Enrollment80 (estimated)
SponsorUppsala University
Academic / other
Locations2 sites (Lund and 1 other locations)
StatusRecruiting
StartedSeptember 1, 2022
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedAugust 19, 2025
Trial IDNCT06335992 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include COPD patients with a forced expiratory volume (FEV1) between 30-85% of predicted, who are non-smokers and free from exacerbations.

Probably not a fit

Patients with unstable cardiovascular or pulmonary diseases or those who regularly participate in specialized exercise programs may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to explore how exercise training can promote lung regeneration in patients with Chronic Obstructive Pulmonary Disease (COPD). The study will evaluate biomarkers related to inflammation, stem cell activity, and tissue regeneration in lung biopsies, blood, and urine samples before and after an exercise program. It hypothesizes that tailored exercise can improve lung function and overall physical capacity by reducing oxidative stress and inflammation. The research also seeks to identify potential targets for future interventions based on the findings.

Why it matters

Potential benefit: If successful, this approach could enhance lung function and quality of life for COPD patients through improved exercise capacity and reduced inflammation.

How similar studies have gone: While the approach of using exercise for COPD management is supported by recent guidelines, the specific molecular mechanisms and biomarkers being studied are novel and less explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Forced expiratory volume in one second (FEV1) 85-30 % of predicted post bronchodilator
* Optimal medical treatment according to GOLD and the Swedish National Guidelines
* Absence of other significant diseases that could contribute to physical exercise limitation
* Non-smoking since at least one year
* Free from exacerbations (last 4 weeks)
* BMI = 18- 35

Exclusion Criteria:

* Regular participation in adjusted/specially designed exercise sessions
* Unstable cardiovascular or pulmonary disease
* Smoking
* Any other criteria that at the discretion of the investigator prevent the study subject from participating in an exercise-training program

Where it's running

  • Lund University
    Lund, Sweden
    Recruiting
  • Uppsala University
    Uppsala, Sweden
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.